Infections and Acute Care
©
Shutterstock
Flu antiviral has bigger benefits for sicker, older patients
A Europe-wide study finds that the antiviral drug, oseltamivir (Tamiflu®), can help people recover from flu-like illness about one-day sooner on average, with older, sicker patients who have been unwell for longer recovering two-to-three days sooner.
Read more
Our research focuses on more effective ways of diagnosing and treating patients with serious and common infections in primary care.
Our research on infections and acute care aims to find out how we can identify patients with serious infection in primary care, and more effective ways of diagnosing and treating patients with common infections and serious, short-term illnesses.
Our research focuses on some of the most conditions patients present to their GP with, aligned with national and international priorities in healthcare. For example, we are investigating more effective interventions to treat common colds and influenza-like illness, as well as looking at how the use of antibiotics can be reduced through more effective prescribing in primary care.
In children, we are particularly interested in improving the evidence base to support primary care professionals to manage a range of common diseases and more serious conditions, from vaccines for whooping cough to early interventions for "at risk" children with influenza-like illness.
Theme leads:
-
Chris Butler
Professor of Primary Care
-
Anthony Harnden
Professor of Primary Care; Director of Graduate Studies
What's new
RCGP Research Paper of the Year awarded to study led by Professor Chris Butler
23 October 2020
The importance of patient and public contributors is recognised as key to the success of the study.
Britain’s most influential Hindu temple spreads awareness of the PRINCIPLE trial among Indian community
21 October 2020
Europe’s BAPS Swaminarayan Sanstha, the largest Hindu temple outside of India, is supporting their community during the coronavirus pandemic by spreading awareness of the PRINCIPLE trial of Covid-19 treatments.
New risk model estimates likelihood of hospitalisation or death from COVID-19
21 October 2020
A new risk model, developed by UK researchers to predict a person’s risk of being admitted to hospital and dying from Covid-19 has been published by The BMJ
Blogs
Can a daily probiotic keep antibiotics at bay?
7 July 2020
Professor Chris Butler, Director of the Primary Care Clinical Trials Unit, writes about the recent PRINCESS trial, which investigated whether probiotics can reduce infections in care home residents.
Setting the research agenda in advanced heart failure
7 July 2020 | 1 comment
Dr Nick Jones, Wellcome Trust Doctoral Research Fellow, writes about the Research Priorities in Advanced Heart Failure project, which has now published its top 10 priorities for the research community.